“…Besides, based on Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) II data (sensitivity 83%, specificity 96%) [34], at a disease prevalence of approximately 5%, the number of false positive patients approaches the number of true positive CTPA studies for the detection of acute PE, and this problem is probably even Prasad et al [2] at the end of their article, rightly stated that "PE captures all the complexity of medicine in the evidence-based era".…”